Individualized Diagnosis and Treatment of Extraesophageal Reflux in Patients With Chronic Cough

Launched by UNIVERSITY HOSPITAL OSTRAVA · Jul 20, 2021

Keywords

ClinConnect Summary

This clinical trial is studying the causes of chronic cough, which is a cough that lasts for three months or longer. One common reason for this type of cough is something called extraesophageal reflux (EER), where stomach contents go back up into the throat. The goal of the study is to accurately diagnose EER in patients who are experiencing chronic cough, whether or not they also have allergies.

If you are between the ages of 18 and 80 and have been dealing with a chronic cough, you might be eligible to participate. However, certain health conditions, like cancers in the head, neck, or lungs, as well as specific chronic lung diseases (except asthma), may prevent you from joining. Those who participate can expect to undergo tests to help identify if EER is contributing to their cough, and they will be helping researchers learn more about how to treat this condition effectively. If you're interested, this could be an important opportunity to find relief from your symptoms.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age 18-80 years
• • patients with chronic cough (cough that lasts 3 months or longer)
• • consent with participation in the study
• Exclusion Criteria:
• • patients using ACE inhibitors or Angiotensin II receptor blockers
• • patients with head and neck cancer
• • patients after radiotherapy in the head and neck area
• • patients with airway or lung cancer
• • patients with chronic lung disease except for bronchial asthma (COPD, interstitial lung disease, bronchiectasis, respiratory bronchiolitis)
• • patients with chronic rhinosinusitis